APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylation. Marino C, Perez-Corredor P, O'Hare M, Heuer A, et al. Alzheimers Dement 2024;20:819-836.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Marino C, Perez-Corredor P, O'Hare M, Heuer A, et al. APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylation. Alzheimers Dement 2024;20:819-836.
PMID: 37791598